SCHEMBL7415374

SCHEMBL7415374

CC(C)(N[C@H](CC(=O)O)Cc1ccc(-c2ccccc2)cc1)P(=O)(O)O

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MMEL1 Q495T6 6/20 0.50
MME P08473 12/20 0.49
ACE P12821 2/20 0.46
ACE2 Q9BYF1 1/20 0.46
ACP3 P15309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7415381 1.00 MMEL1 (0.50) MMEL1MMEACEACE2ACP3
SCHEMBL7415269 0.89 MME (0.44) MMEL1MMEACEACE2ACP3
SCHEMBL7415260 0.89 MME (0.44) MMEL1MMEACEACE2ACP3
SCHEMBL7411683 0.87 MME (0.60) MMEL1MMEACEACE2
SCHEMBL7411695 0.87 MME (0.60) MMEL1MMEACEACE2
SCHEMBL7407207 0.85 MME (0.48) MMEL1MMEACEACP3
SCHEMBL7407197 0.85 MME (0.48) MMEL1MMEACEACP3
SCHEMBL7322706 0.82 MME (0.59) MMEACEACE2ACP3
SCHEMBL7348036 0.82 MME (0.59) MMEACEACE2ACP3
SCHEMBL8921943 0.80 MMEL1 (0.48) MMEL1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0660840-B1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA GEIGY AG (CH) 1997-05-07 EP disclosed
WO-1996026729-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES AS ECE INHIBITORS CIBA-GEIGY AG (CH) 1996-09-06 WO disclosed
US-5550119-A ENDOTHELIN-CONVERTING ENZYM INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-08-27 US disclosed
EP-0660840-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES. CIBA GEIGY AG (CH) 1995-07-05 EP disclosed
WO-1994005677-A1 PHOSPHONO SUBSTITUTED TETRAZOLE DERIVATIVES CIBA-GEIGY AG (CH) 1994-03-17 WO disclosed
US-5250522-A Neutral endopeptidase inhibitors; cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-10-05 US disclosed